Literature DB >> 31999354

Induction of Labor: An Overview of Guidelines.

Ioannis Tsakiridis1, Apostolos Mamopoulos2, Apostolos Athanasiadis2, Themistoklis Dagklis3.   

Abstract

IMPORTANCE: Induction of labor (IOL) is a common obstetric intervention that stimulates the onset of labor using artificial methods.
OBJECTIVE: The aim of this study was to summarize and compare recommendations from 4 national or international medical societies on the IOL. EVIDENCE ACQUISITION: A descriptive review was conducted of major published guidelines on IOL: the American College of Obstetricians and Gynecologists' "Induction of Labor" and "Management of Late-Term and Postterm Pregnancies," the guidelines of the Society of Obstetricians and Gynaecologists of Canada (SOGC) on "Induction of Labour," those of the National Institute for Health and Care Excellence (NICE) on "Inducing Labour," and the World Health Organization's (WHO's) "Recommendations for Induction of Labour" and "WHO Recommendations: Induction of Labour at or Beyond Term." These guidelines were compared in terms of their recommendations on clinical indications and methods.
RESULTS: Many similar indications and contraindications to IOL are identified between American College of Obstetricians and Gynecologists and SOGC, whereas NICE and WHO do not mention any contraindications. The timing of IOL in postterm pregnancies also differs among the guidelines. Regarding the methods of induction, all the medical societies recommend the use of membrane sweeping, mechanical methods, prostaglandins, and oxytocin, whereas NICE argues against the use of misoprostol for IOL. The American College of Obstetricians and Gynecologists and SOGC consider amniotomy a method of IOL, whereas NICE and WHO do not recommend it. All the guidelines also make similar recommendations regarding the management of uterine tachysystole in cases of IOL.
CONCLUSIONS: The World Health Organization seems to be the most evidence-based guideline with recommendations based mainly on Cochrane reviews. The variation in the clinical indications and methods of IOL highlights the need to adopt an international consensus, which may help to optimize the quality of obstetric care and further promote evidence-based medicine.

Entities:  

Mesh:

Year:  2020        PMID: 31999354     DOI: 10.1097/OGX.0000000000000752

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  6 in total

1.  Change in timing of induction protocol in nulliparous women to optimise timing of birth: results from a single centre study.

Authors:  Laura Slade; Georgina Digance; Angela Bradley; Richard Woodman; Rosalie Grivell
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-13       Impact factor: 3.007

2.  Outpatient Induction of Labor - Are Balloon Catheters an Appropriate Method?

Authors:  Werner Rath; Patrick Stelzl; Sven Kehl
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-01-19       Impact factor: 2.754

3.  Predicting the success of induction of labour using cervical volume.

Authors:  Malitha Patabendige; Sanka Rajesh Athulathmudali
Journal:  BMC Res Notes       Date:  2021-12-18

4.  Retrospective Analysis of the Factors Affecting the Induction of Childbirth in 4350 Women from a Single Center in Warsaw, Poland.

Authors:  Grażyna Bączek; Ewa Rzońca; Patryk Rzońca; Sylwia Rychlewicz; Margareta Budner; Agnieszka Bień
Journal:  Int J Environ Res Public Health       Date:  2022-08-03       Impact factor: 4.614

5.  Effect of Oxytocin Combined with Different Volume of Water Sac in High-Risk Term Pregnancies.

Authors:  Hanna Mi; Na Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-06       Impact factor: 2.650

6.  Use of induction of labour and emergency caesarean section and perinatal outcomes in English maternity services: a national hospital-level study.

Authors:  Ipek Gurol-Urganci; Jennifer Jardine; Fran Carroll; Alissa Frémeaux; Patrick Muller; Sophie Relph; Lara Waite; Kirstin Webster; Sam Oddie; Jane Hawdon; Tina Harris; Asma Khalil; Jan van der Meulen
Journal:  BJOG       Date:  2022-04-21       Impact factor: 7.331

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.